X
All Data
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
Lead Product(s): AZR-MD-001
Therapeutic Area: Ophthalmology Product Name: AZR-MD-001
Highest Development Status: Phase II/ Phase III Product Type: Undisclosed
Partner/Sponsor/Collaborator: OrbiMed
Deal Size: $20.0 million Upfront Cash: Undisclosed
Deal Type: Financing October 22, 2020
Details:
On the back of encouraging Phase 2 data to date proceeds from the funding round will be used to advance Azura’s lead product candidate AZR-MD-001 through a registration study for the treatment of MGD.
Active Pharmaceutical Ingredients
Finished Drug Formulations
Prices
Excipients
Services
Marketplace
